Fig. 1From: CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1The proliferation of HCCLM3 cells by CCK-8 assay. A The inhibition rate of CSP I-plus at a different concentration for 24, 48, and 72 h; B The inhibition rate of Endostar at a different concentration for 24, 48, and 72 h; C The inhibition rate of rES-CSP at a different concentration for 24, 48, and 72 hBack to article page